X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (184) 184
index medicus (123) 123
male (89) 89
female (88) 88
middle aged (75) 75
hypertension (65) 65
aged (60) 60
pharmacology & pharmacy (57) 57
risk factors (51) 51
adult (46) 46
statins (41) 41
medicine, general & internal (39) 39
chronic kidney disease (32) 32
oxidative stress (32) 32
peripheral vascular disease (30) 30
atherosclerosis (29) 29
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (29) 29
cardiac & cardiovascular systems (28) 28
randomized controlled trials as topic (28) 28
hemodialysis (26) 26
medical colleges (26) 26
analysis (25) 25
animals (25) 25
c-reactive protein (24) 24
cardiovascular diseases (24) 24
care and treatment (24) 24
risk (24) 24
treatment outcome (24) 24
biomarkers - blood (23) 23
cardiovascular disease (22) 22
cardiovascular-disease (22) 22
medicine, research & experimental (22) 22
mortality (22) 22
coronary-heart-disease (21) 21
heart failure (21) 21
inflammation (21) 21
therapy (21) 21
blood pressure (20) 20
lipids (20) 20
biochemistry & molecular biology (19) 19
blood-pressure (19) 19
cardiovascular (19) 19
research (19) 19
urology & nephrology (19) 19
clinical research (18) 18
medicine & public health (18) 18
chronic kidney-disease (17) 17
renal dialysis (17) 17
risk-factors (17) 17
chronic kidney failure (16) 16
coronary-artery-disease (16) 16
myocardial-infarction (16) 16
association (15) 15
cardiovascular diseases - prevention & control (15) 15
cholesterol (15) 15
dialysis (15) 15
aged, 80 and over (14) 14
atorvastatin (14) 14
atrial fibrillation (14) 14
biomarkers (14) 14
heart diseases (14) 14
meta-analysis (14) 14
review (14) 14
studies (14) 14
cardiovascular events (13) 13
diagnosis (13) 13
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (13) 13
kidney diseases (13) 13
nutrition & dietetics (13) 13
prevention (13) 13
renal insufficiency, chronic - complications (13) 13
acute myocardial-infarction (12) 12
brain natriuretic peptide (12) 12
case-control studies (12) 12
diabetes (12) 12
double-blind (12) 12
endothelial dysfunction (12) 12
heart-failure (12) 12
hypertension - drug therapy (12) 12
metabolic syndrome (12) 12
nephrology (12) 12
cardiovascular diseases - drug therapy (11) 11
cardiovascular risk (11) 11
heart (11) 11
hypertension - physiopathology (11) 11
internal medicine (11) 11
obesity (11) 11
pilot projects (11) 11
activation (10) 10
antihypertensive agents - therapeutic use (10) 10
cardiology (10) 10
complications and side effects (10) 10
dyslipidemia (10) 10
dyslipidemias - drug therapy (10) 10
epidemiology (10) 10
health aspects (10) 10
hemodialysis-patients (10) 10
hypertension - blood (10) 10
nitric-oxide synthase (10) 10
predictors (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CURRENT PHARMACEUTICAL BIOTECHNOLOGY, ISSN 1389-2010, 2017, Volume 18, Issue 4, pp. 303 - 308
Journal Article
Current Vascular Pharmacology, ISSN 1570-1611, 2015, Volume 13, Issue 1, pp. 134 - 140
Background: The most common complications of chronic kidney disease (CKD) are hypertension and cardiovascular (CV) disorders. Renalase is produced and released... 
Hypertension | Cardiovascular disease | Renalase | Chronic kidney disease | Dialysis | dialysis | chronic kidney disease | NOREPINEPHRINE | BLOOD-PRESSURE | PLASMA | renalase | DOPAMINE | PHARMACOLOGY & PHARMACY | PERIPHERAL VASCULAR DISEASE | hypertension | SODIUM-DEPENDENT MODULATION | EXPRESSION
Journal Article
Nutrition, ISSN 0899-9007, 2016, Volume 32, Issue 11-12, pp. 1179 - 1192
Journal Article
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2013, Volume 19, Issue 27, pp. 4904 - 4912
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 11/2017, Volume 23, Issue 39, pp. 6086 - 6095
Background: All stages of chronic kidney disease (CKD) are associated with increased risks of atherosclerosis and cardiovascular morbidity and mortality.... 
HDL | Biomarker | LDL subfractions | H-FABP | Dialysis | GDF-15 | Copeptin | copeptin | MARKER | SUBFRACTIONS | PREVALENCE | biomarker | HIGH-DENSITY-LIPOPROTEIN | DIFFERENTIATION FACTOR 15 | ACID-BINDING PROTEIN | PHARMACOLOGY & PHARMACY | h-FABP | CHRONIC KIDNEY-DISEASE
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2014, Volume 21, Issue 25, pp. 2910 - 2916
Chronic kidney disease (CKD) is an emerging health hazard, connected to very high cardiovascular mortality due to accelerated atherosclerosis. Increased... 
Dysfunctional HDL | Chronic kidney disease | CAD risk | Atherosclerosis | INHIBITION REVERSES LCAT |